2025-2034 Renal Biomarkers Market Evolution: Disruptions, Innovations, and Untapped Opportunities

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations._x000D_
_x000D_
What Is the Expected CAGR for the Renal Biomarkers Market Through 2025?_x000D_
There has been a significant expansion in the renal biomarkers market size over the preceding years. The market, presently valued at $1.28 billion in 2024, is predicted to increase to $1.38 billion by 2025, reflecting a compound annual growth rate (CAGR) of 7.8%. The surge seen in the historical period is linked to a rise in kidney illnesses, advancements in medical diagnostic techniques, an aging populace, heightened perception of proactive disease detection, the incorporation of point-of-care testing, and the escalating number of chronic disease cases._x000D_
_x000D_
What's the Projected Size of the Global Renal Biomarkers Market by 2029?_x000D_
In the coming years, the renal biomarkers market is projected to experience substantial growth, escalating to a value of $1.91 billion in 2029 with an 8.5% compound annual growth rate (CAGR). The forecasted growth can be linked to factors such as the rise of personalized and targeted therapies, the incorporation of biomarker testing as a regular part of clinical practice, developing markets in Asia and Latin America, the adoption of non-invasive biomarker testing procedures, and constant monitoring through wearable technology. Expected trends during this period encompass multiplex biomarker panels for complete disease profiling, the use of artificial intelligence and machine learning in biomarker discovery, companion diagnostics based on biomarkers, point-of-care biomarker testing in domestic healthcare environments, and biomarkers geared towards early detection and prevention of diseases._x000D_
_x000D_
View the full report here:_x000D_
https://www.thebusinessresearchcompany.com/report/renal-biomarkers-global-market-report_x000D_
_x000D_
Top Growth Drivers in the Renal Biomarkers Industry: What's Accelerating the Market?_x000D_
An increase in elderly and young renal patients is anticipated to drive the growth of the renal biomarkers market in the future. Elderly renal patients are typically those aged over 70 with an advanced form of chronic kidney disease (CKD), while young renal patients are usually diagnosed with kidney disorders in their childhood or early adult years. Renal biomarkers serve a crucial role in assessing the extent of kidney damage in these patients. As an example, in June 2024, the Australia-based government agency, Australian Institute of Health and Welfare, reported a rise in CKD mortality rates by 4.2% in 2021 and 6.2% in 2022. Thus, the increasing population of elderly and young renal patients is fostering the growth of the renal biomarkers market._x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=7711&type=smp_x000D_
_x000D_
What Trends Will Shape the Renal Biomarkers Market Through 2029 and Beyond?_x000D_
Revolutionary technological breakthroughs have arisen as a significant trend in the renal biomarkers market. The key players in this sector are concentrating their efforts on craft innovative technologies to maintain their standing in the market. For example, in March 2022, Nipro Medical Corporation, a company based in the US that produces medical equipment, unveiled the SURDIAL DX. This state-of-the-art hemodialysis system utilizes current technology to prioritize patient safety, comfort, and efficiency. It incorporates an array of modern design aspects such as simplified automated processes, ergonomic design features, and dedication to improve the dialysis treatment journey altogether._x000D_
_x000D_
What Are the Main Segments in the Renal Biomarkers Market?_x000D_
The renal biomarkers market covered in this report is segmented -_x000D_
_x000D_
1) By Biomarker Type: Functional Biomarker, Up Regulated Protein, Other Biomarker Types_x000D_
2) By Diagnostic Technique: Enzyme-Linked Immunosorbent Assay, Particle-Enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LS-MS)_x000D_
3) By Application: Diagnosis And Disease Progression Monitoring, Research Homecare_x000D_
4) By End User: Hospitals, Diagnostic Laboratories, Other End Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Functional Biomarker: Creatinine, Urea, Cystatin C, Bicarbonate_x000D_
2) By Up Regulated Protein: Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1), Interleukin-18 (IL-18)_x000D_
3) By Other Biomarker Types: Proximal Tubule Injury Biomarkers, Acute Kidney Injury Biomarkers, Chronic Kidney Disease Biomarkers_x000D_
_x000D_
Tailor your insights and customize the full report here:_x000D_
https://www.thebusinessresearchcompany.com/customise?id=7711&type=smp_x000D_
_x000D_
Which Top Companies are Driving Growth in the Renal Biomarkers Market?_x000D_
Major companies operating in the renal biomarkers market include Abbott Laboratories, BioPorto Diagnostics A/S, Roche Holding AG, Thermo Fisher Scientific, bioMérieux SA, Randox Laboratories, Siemens Healthineers, Beckman Coulter Inc., Astute Medical Inc., Nexelis Company, Sphingotec GmbH, Bio-Rad Laboratories India Pvt. Ltd., Enzo Biochem Inc., PerkinElmer Inc., Novartis AG, Alere Inc., AstraZeneca plc, Bio-Techne Corp., DiaSorin S.p.A., EKF Diagnostics Holdings plc, Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Merck KGaA, Myriad RBM Inc., Ortho Clinical Diagnostics Holdings plc, Quidel Corporation, R&D Systems Inc., Roche Diagnostics International Ltd ., Sekisui Chemical Co. Ltd., Sysmex Corporation, Tosoh Bioscience Inc._x000D_
_x000D_
Which Regions Will Dominate the Renal Biomarkers Market Through 2029?_x000D_
North America was the largest region in the renal biomarkers market in 2024. Asia-Pacific is expected to be the fastest-growing region during the forecast period. The regions covered in the renal biomarkers market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_
_x000D_
Purchase the full report today:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7711_x000D_
_x000D_
This Report Supports:_x000D_
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions._x000D_
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning._x000D_
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks._x000D_
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work._x000D_
_x000D_

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.